R01CA292860 (WEICHSELBAUM, RALPH R)Jul 1, 2024 - Jun 30, 2029 NIH Genetically-engineered Bacteria Overcome Therapy Resistance Role: Principal Investigator |
|
R01CA276307 (WEICHSELBAUM, RALPH R)Jun 1, 2023 - May 31, 2028 NIH Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer Role: Principal Investigator |
|
U54CA274291 (FORMENTI, SILVIA C.)Sep 21, 2022 - Jul 31, 2027 NIH Dynamics of Immune Response in Irradiated Rectal Cancer Role: Co-Principal Investigator |
|
R21CA267607 (WEICHSELBAUM, RALPH R)Aug 16, 2022 - Jul 31, 2024 NIH In vivo CRISPR-screening of novel cancer cell-intrinsic targets that sensitize to local ionizing radiation, and possible combination with systemic checkpoint blockade. Role: Principal Investigator |
|
R01CA262508 (WEICHSELBAUM, RALPH R)Jul 1, 2021 - Jun 30, 2026 NIH Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy Role: Principal Investigator |
|
R01CA253655 (LIN, WENBIN)Jul 1, 2020 - Jun 30, 2025 NIH Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers Role: Co-Principal Investigator |
|
R21CA231273 (WEICHSELBAUM, RALPH R)Aug 6, 2019 - Jul 31, 2021 NIH Microbiota and the anti-tumor action of anti-CD47 immunomodulation. Role: Principal Investigator |
|
R21CA226582 (WEICHSELBAUM, RALPH R)Jul 1, 2019 - Jun 30, 2021 NIH Therapeutic use of T cells engineered to produce radiation-inducible cytokines Role: Principal Investigator |
|
R21CA227528 (WEICHSELBAUM, RALPH R)Sep 6, 2018 - Aug 31, 2020 NIH (PQ10) Understanding How Commensal Microbiota Affect the Anti-tumor Action of Radiotherapy Role: Principal Investigator |
|
R21CA195075 (WEICHSELBAUM, RALPH R)Mar 15, 2016 - Feb 28, 2019 NIH Enhancing the abscopal effect in cancer treatment by immune modulation Role: Principal Investigator |
|
U01CA198989 (LIN, WENBIN)Sep 25, 2015 - Jul 31, 2021 NIH Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers Role: Co-Principal Investigator |
|
R01CA199663 (KRON, STEPHEN J.)Jul 16, 2015 - Jun 30, 2021 NIH Image-guided radiation-induced permeability (IGRIP) for IGDD Role: Co-Principal Investigator |
|
R01CA111423 (WEICHSELBAUM, RALPH R)Sep 26, 2005 - Jul 31, 2011 NIH Mechanisms of Resistance to Radio Inducible Gene Therapy Role: Principal Investigator |
|
R01CA113662 (WEICHSELBAUM, RALPH R)Mar 1, 2005 - Feb 28, 2011 NIH DNA Damage Targeted Gene Therapy in Head &Neck Cancer Role: Principal Investigator |
|
R01HL067109 (WEICHSELBAUM, RALPH R)Feb 20, 2002 - Jan 31, 2007 NIH Gene Therapy for Extension of Vein Graft Patency Role: Principal Investigator |
|
U01CA060268 (WEICHSELBAUM, RALPH R)Jun 1, 1993 - Sep 30, 1997 NIH 3D DOSE ESCALATION FOR PROSTATE CANCER Role: Principal Investigator |
|
R01CA042596 (WEICHSELBAUM, RALPH R)Feb 1, 1986 - Apr 30, 2001 NIH NOVEL METHODS OF TUMOR CELL RADIOSENSITIZATION Role: Principal Investigator |
|
R01CA041068 (WEICHSELBAUM, RALPH R)May 1, 1985 - Mar 31, 1998 NIH RADIATION GENE INDUCTION--APPLICATIONS TO GENE TARGETING Role: Principal Investigator |
|
T32CA009273 (WEICHSELBAUM, RALPH R)Sep 30, 1978 - Mar 31, 2002 NIH TRAINING PROGRAM IN ENVIRONMENTAL BIOLOGY (NRSA) Role: Principal Investigator |